Benitec Biopharma Limited Stock Company Profile
Information
3940 Trust Way
Hayward CA 94545
510 780 0819
benitec.com
Industry: Biotechnology
Sector: Healthcare

Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.